It has also been found that in APP/PS1 transgenic mice, AEP activity was elevated during the early stages of Alzheimer’s disease—prior to the appearance of senile plaques and cognitive decline. Here, PSEN1 is linked to early-onset autosomal dominant Alzheimer disease.